Hjem › Livmorkreft › New York
Kliniske studier for Livmorkreft i New York
8 studier for Livmorkreft søker deltakere på steder i New York.
Byer i New York
Offisiell studietekst (engelsk)
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
- Maimonides Medical Center, Brooklyn
- Columbia University Medical Center - Herbert Irving Pavilion, New York
- IP Address: Columbia University Medical Center/New York Presbyterian Hospital Research Pharmacy, New York
RekruttererFase 4
Alder 18 og eldre · Kvinner · Oppdatert 25. sep. 2026 · NCT06952660DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Research Site, New York
RekruttererFase 3
Alder 18 og eldre · Kvinner · Oppdatert 3. sep. 2026 · NCT06989112PIPAC for the Treatment of Peritoneal Carcinomatosis in Patients With Ovarian, Uterine, Appendiceal, Colorectal, or Gastric Cancer
- Northwell Health Cancer Institute at Huntington, Greenlawn
RekruttererFase 1
Alder 18 og eldre · Alle kjønn · Oppdatert 26. aug. 2026 · NCT04329494Investigations of Reproductive Cancers in Women
- Columbia University, New York
RekruttererObservasjonsstudie
Alder 45 til 100 · Kvinner · Oppdatert 17. aug. 2026 · NCT06527157Sacituzumab Govitecan in Combination With Cisplatin in Platinum Sensitive Recurrent Ovarian and Endometrial Cancer
- Icahn School of Medicine at Mount Sinai Division of Hematology and Medical Oncology, New York
RekruttererFase 1/2
Alder 18 og eldre · Kvinner · Oppdatert 13. aug. 2026 · NCT06040970Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected Endometrial Cancer (Bluestar-Endometrial01)
- Research Site, Brooklyn
- Research Site, Stony Brook
- Research Site, The Bronx
- og 1 flere
RekruttererFase 3
Alder 18 og eldre · Kvinner · Oppdatert 29. jul. 2026 · NCT07044336A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations
- Columbia University Irving Medical Center, New York
- Memorial Sloan Kettering Cancer Center, New York
RekruttererFase 2
Alder 8 og eldre · Alle kjønn · Oppdatert 27. jul. 2026 · NCT05503797NYSCF Scientific Discovery Biobank
- New York Stem Cell Foundation Research Institute, New York
RekruttererObservasjonsstudie
30 Days · Alle kjønn · Oppdatert 3. mar. 2025 · NCT06203106Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.